NeuroPace Inc — Director's Dealing 2021

Apr 20, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-20

Reporting Person: Ridley Irina (General Counsel and Secretary)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.04	2031-01-20	Common Stock (92308)		Direct

Footnotes

F1: 25% of the shares subject to the option vest on December 30, 2021; 1/48th of the total shares subject to the option vest in 36 equal monthly installments thereafter.